These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 18930637

  • 1. Single voxel magnetic resonance spectroscopy at 3 Tesla in a memory disorders clinic: early right hippocampal NAA/Cr loss in mildly impaired subjects.
    Caserta MT, Ragin A, Hermida AP, Ahrens RJ, Wise L.
    Psychiatry Res; 2008 Nov 30; 164(2):154-9. PubMed ID: 18930637
    [Abstract] [Full Text] [Related]

  • 2. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, Yurgelun-Todd DA, Cohen BM, Renshaw PF.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec 30; 28(8):1313-22. PubMed ID: 15588758
    [Abstract] [Full Text] [Related]

  • 3. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM, Gavrila D, Antúnez C, Tormo MJ, Salmerón D, Carles R, Jiménez Veiga J, Parrilla G, Torres del Río S, Fortuna L, Navarro C.
    Dement Geriatr Cogn Disord; 2008 Dec 30; 26(1):15-25. PubMed ID: 18566544
    [Abstract] [Full Text] [Related]

  • 4. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T, Xiao S, Li X, Ding B, Ling H, Chen K, Fang Y.
    Int Psychogeriatr; 2012 Jan 30; 24(1):19-27. PubMed ID: 21676281
    [Abstract] [Full Text] [Related]

  • 5. The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study.
    Waldman AD, Rai GS.
    Neuroradiology; 2003 Aug 30; 45(8):507-12. PubMed ID: 12879326
    [Abstract] [Full Text] [Related]

  • 6. Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment.
    Foy CM, Daly EM, Glover A, O'Gorman R, Simmons A, Murphy DG, Lovestone S.
    Brain Topogr; 2011 Oct 30; 24(3-4):316-22. PubMed ID: 21298332
    [Abstract] [Full Text] [Related]

  • 7. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z, Zhao C, Yu L, Zhou W, Li K.
    Acta Radiol; 2009 Apr 30; 50(3):312-9. PubMed ID: 19235582
    [Abstract] [Full Text] [Related]

  • 8. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
    Pilatus U, Lais C, Rochmont Adu M, Kratzsch T, Frölich L, Maurer K, Zanella FE, Lanfermann H, Pantel J.
    Psychiatry Res; 2009 Jul 15; 173(1):1-7. PubMed ID: 19427767
    [Abstract] [Full Text] [Related]

  • 9. Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy.
    Metastasio A, Rinaldi P, Tarducci R, Mariani E, Feliziani FT, Cherubini A, Pelliccioli GP, Gobbi G, Senin U, Mecocci P.
    Neurobiol Aging; 2006 Jul 15; 27(7):926-32. PubMed ID: 15936850
    [Abstract] [Full Text] [Related]

  • 10. Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
    Targosz-Gajniak MG, Siuda JS, Wicher MM, Banasik TJ, Bujak MA, Augusciak-Duma AM, Opala G.
    J Neurol Sci; 2013 Dec 15; 335(1-2):58-63. PubMed ID: 24035276
    [Abstract] [Full Text] [Related]

  • 11. A Critical Proton MR Spectroscopy Marker of Alzheimer's Disease Early Neurodegenerative Change: Low Hippocampal NAA/Cr Ratio Impacts APOE ɛ4 Mexico City Children and Their Parents.
    Calderón-Garcidueñas L, Mora-Tiscareño A, Melo-Sánchez G, Rodríguez-Díaz J, Torres-Jardón R, Styner M, Mukherjee PS, Lin W, Jewells V.
    J Alzheimers Dis; 2015 Dec 15; 48(4):1065-75. PubMed ID: 26402110
    [Abstract] [Full Text] [Related]

  • 12. Proxies of cognitive reserve and their effects on neuropsychological performance in patients with mild cognitive impairment.
    Liu Y, Cai ZL, Xue S, Zhou X, Wu F.
    J Clin Neurosci; 2013 Apr 15; 20(4):548-53. PubMed ID: 23406880
    [Abstract] [Full Text] [Related]

  • 13. Maturation of limbic regions in Asperger syndrome: a preliminary study using proton magnetic resonance spectroscopy and structural magnetic resonance imaging.
    O'Brien FM, Page L, O'Gorman RL, Bolton P, Sharma A, Baird G, Daly E, Hallahan B, Conroy RM, Foy C, Curran S, Robertson D, Murphy KC, Murphy DG.
    Psychiatry Res; 2010 Nov 30; 184(2):77-85. PubMed ID: 20952166
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study.
    Huang W, Alexander GE, Chang L, Shetty HU, Krasuski JS, Rapoport SI, Schapiro MB.
    Neurology; 2001 Aug 28; 57(4):626-32. PubMed ID: 11524470
    [Abstract] [Full Text] [Related]

  • 16. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
    Almuqbel M, Melzer TR, Myall DJ, MacAskill MR, Pitcher TL, Livingston L, Wood KL, Keenan RJ, Dalrymple-Alford JC, Anderson TJ.
    Parkinsonism Relat Disord; 2016 Jan 28; 22():54-61. PubMed ID: 26627939
    [Abstract] [Full Text] [Related]

  • 17. [Alzheimer's disease and magnetic resonance spectroscopy of the hippocampus].
    Engelhardt E, Moreira DM, Laks J, Marinho VM, Rozenthal M, Oliveira AC.
    Arq Neuropsiquiatr; 2001 Dec 28; 59(4):865-70. PubMed ID: 11733829
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N, Ising M, Schreiber YA, Atiya M, Sonntag A, Auer DP.
    Neurosci Lett; 2001 Dec 28; 384(1-2):23-8. PubMed ID: 15905028
    [Abstract] [Full Text] [Related]

  • 20. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
    Bittner DM, Heinze HJ, Kaufmann J.
    J Alzheimers Dis; 2013 Dec 28; 36(1):155-63. PubMed ID: 23579327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.